Applicant	Tradename	Generic Name	NDA	Approval Date	Type	RLD	Patent Number	Delist Req.	Patent Expiration
Astrazeneca	ATACAND	candesartan cilexetil	020838	Jun 4, 1998	RX	No	5,196,444*PED	Y	Dec 4, 2012
Astrazeneca	ATACAND	candesartan cilexetil	020838	Jun 4, 1998	RX	No	5,534,534*PED	Y	Jan 9, 2014
Astrazeneca	ATACAND	candesartan cilexetil	020838	Jun 4, 1998	RX	No	5,705,517*PED	Y	Oct 18, 2011

Export available with Ultimate Plan subscription:

This preview shows a limited data set. Complete access is available with a Subscription

Paragraph IV activity for: ATACAND

Drugname	Dosage	Strength	RLD	Submissiondate
candesartan cilexetil and hydrochlorothiazide	Tablets	32 mg/25 mg	Atacand HCT	3/6/2009
candesartan cilexetil and hydrochlorothiazide	Tablets	16 mg/12.5 mg and 32 mg/12.5 mg	Atacand HCT	6/25/2008
candesartan cilexetil	Tablets	4 mg, 8 mg, 16 mg and 32 mg	Atacand	12/22/2006

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:
2000 2001 2002 2003 2004
2005 2006 2007 2008 2009

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Follow DrugPatentWatch on Twitter

Bookmark or Share This Page ...